A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults

Clinical trial NCT05526911 · COMPLETED

Trial details

NCT number: NCT05526911
Sponsor: Global Alliance for TB Drug Development
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Disease Tuberculosis, Pulmonary Tuberculosis Multi Drug Resistant Tuberculosis Drug Sensitive Tuberculosis Drug-resistant Tuberculosis Mycobacterium Tuberculosis Infection

Start date: 2022-06-30
Primary completion: 2022-09-26
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.